NASDAQ:NRC National Research (NRC) Stock Price, News & Analysis $12.63 -0.63 (-4.75%) Closing price 04:00 PM EasternExtended Trading$12.61 -0.02 (-0.16%) As of 05:23 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Stock Analysis Stock AnalysisChartCompetitorsDividendEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock About National Research Stock (NASDAQ:NRC) 30 days 90 days 365 days Advanced Chart View Price History Chart DataSkip Price History Chart Get National Research alerts:Sign Up Key Stats Today's Range$12.32▼$13.3450-Day Range$13.30▼$17.2452-Week Range$9.76▼$27.07Volume164,016 shsAverage Volume91,315 shsMarket Capitalization$287.71 millionP/E Ratio16.62Dividend Yield3.80%Price TargetN/AConsensus RatingN/A Company Overview National Research Corporation provides analytics and insights that facilitate measurement and enhancement of the patient and employee experience. Its portfolio of subscription-based solutions provides actionable information and analysis to healthcare organizations across a range of mission-critical, constituent-related elements, including patient experience, service recovery, care transitions, employee engagement, reputation management, and brand loyalty. The company also offers marketing solutions that allow the tracking of awareness, perception, and consistency of healthcare brands; assessment of competitive differentiators; and enhanced segmentation tools to evaluate needs, wants, and behaviors of communities through real-time competitive assessments and enhanced segmentation tools. In addition, it provides experience solutions, such as patient experience, employee engagement, health risk assessments, care transition, and improvement tools. Further, the company provides reputation solutions that allow healthcare organizations to share a picture of their organization and ensure that timely and relevant content informs consumer decision-making; and governance solutions for not-for-profit hospital and health system boards of directors, executives, and physician leadership. National Research Corporation was founded in 1981 and is headquartered in Lincoln, Nebraska. Read More National Research Stock Analysis - MarketRank™See Top-Rated MarketRank™ Stocks56th Percentile Overall ScoreNRC MarketRank™: National Research scored higher than 56% of companies evaluated by MarketBeat, and ranked 150th out of 312 stocks in the business services sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation. Analyst's OpinionN/AAnalyst RatingN/A Consensus RatingThere is not enough analysis data for National Research. Earnings and Valuation1.3 / 5Proj. Earnings GrowthN/A Price to Earnings Ratio vs. the MarketThe P/E ratio of National Research is 16.72, which means that it is trading at a less expensive P/E ratio than the market average P/E ratio of about 27.63.Price to Earnings Ratio vs. SectorThe P/E ratio of National Research is 16.72, which means that it is trading at a less expensive P/E ratio than the Business Services sector average P/E ratio of about 28.88.Price to Book Value per Share RatioNational Research has a P/B Ratio of 9.34. P/B Ratios above 3 indicate that a company could be overvalued with respect to its assets and liabilities.Read more about National Research's valuation and earnings. Short Interest4.0 / 5Short Interest LevelHealthy Percentage of Shares Shorted3.74% of the float of National Research has been sold short.Short Interest Ratio / Days to CoverNational Research has a short interest ratio ("days to cover") of 4.8.Change versus previous monthShort interest in National Research has recently decreased by 5.58%, indicating that investor sentiment is improving significantly. Dividend1.7 / 5Dividend StrengthWeak Dividend YieldNational Research pays a meaningful dividend of 3.44%, higher than the bottom 25% of all stocks that pay dividends.Dividend GrowthNational Research does not have a long track record of dividend growth.Dividend CoverageThe dividend payout ratio of National Research is 46.60%. This payout ratio is at a healthy, sustainable level, below 75%.Read more about National Research's dividend. Sustainability and ESGN/AEnvironmental ScoreN/A Percentage of Shares Shorted3.74% of the float of National Research has been sold short.Short Interest Ratio / Days to CoverNational Research has a short interest ratio ("days to cover") of 4.8.Change versus previous monthShort interest in National Research has recently decreased by 5.58%, indicating that investor sentiment is improving significantly. News and Social Media2.8 / 5News Sentiment1.01 News SentimentNational Research has a news sentiment score of 1.01. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This news sentiment score is similar to the average news sentiment of Business Services companies.News Coverage This WeekMarketBeat has tracked 6 news articles for National Research this week, compared to 2 articles on an average week.MarketBeat Follows1 people have added National Research to their MarketBeat watchlist in the last 30 days. Company Ownership2.5 / 5Insider TradingAcquiring Shares Insider Buying vs. Insider SellingIn the past three months, National Research insiders have bought more of their company's stock than they have sold. Specifically, they have bought $33,975.00 in company stock and sold $0.00 in company stock.Percentage Held by InsidersOnly 2.00% of the stock of National Research is held by insiders.Percentage Held by Institutions47.26% of the stock of National Research is held by institutions. High institutional ownership can be a signal of strong market trust in this company.Read more about National Research's insider trading history. Receive NRC Stock News and Ratings via Email Sign-up to receive the latest news and ratings for National Research and its competitors with MarketBeat's FREE daily newsletter. Email Address NRC Stock News HeadlinesNRC Health Announces Second Quarter 2025 ResultsJuly 28 at 6:11 PM | businesswire.comNRC Eyes New Accident Tolerant Nuclear Fuels For Commercial UseJuly 27 at 1:46 PM | forbes.comThe End of Elon Musk…?The End of Elon Musk? Don't make him laugh. Jeff Brown has been hearing this same tired story for years, and he's been proven right time and time again. And now, while the media focuses on Tesla's "demise," he's uncovered an AI breakthrough that's about to make Elon's doubters eat their words yet again. According to his research, if you listen to the media and miss out on Elon's newest breakthrough, it's going to cost you the fortune of a lifetime.July 30 at 2:00 AM | Brownstone Research (Ad)Arunachal minister presents 10-point agenda at ICAR AGM, pushes for skill based agri-educationJuly 8, 2025 | msn.comGlycovax Pharma launches a highly performant SLA AdjuvantJuly 8, 2025 | finance.yahoo.comNRC: No major misuse of funds by Holtec International at Palisades Nuclear PlantJuly 5, 2025 | msn.comNRC National Research Corporation - Seeking AlphaJune 26, 2025 | seekingalpha.comNational Research Solidifies Dividend Amid Insider Buying and Contract GrowthJune 26, 2025 | msn.comSee More Headlines NRC Stock Analysis - Frequently Asked Questions How have NRC shares performed this year? National Research's stock was trading at $17.64 at the beginning of the year. Since then, NRC stock has decreased by 28.0% and is now trading at $12.7050. How were National Research's earnings last quarter? National Research Corporation (NASDAQ:NRC) issued its earnings results on Monday, July, 28th. The company reported $0.28 EPS for the quarter. The firm had revenue of $34.04 million for the quarter. National Research had a trailing twelve-month return on equity of 76.61% and a net margin of 12.78%. Read the conference call transcript. Does National Research have any subsidiaries? The following companies are subsidiaries of National Research: PatientWisdom Inc., The Governance Institute, and National Research Corporation Canada. Who are National Research's major shareholders? Top institutional investors of National Research include US Bancorp DE (0.17%), Vanguard Personalized Indexing Management LLC (0.12%), Inspire Investing LLC (0.10%) and Significant Wealth Partners LLC (0.06%). Insiders that own company stock include Amandla Mk Trust, Patrick E Beans, Kevin R Karas and Jona S Raasch. View institutional ownership trends. How do I buy shares of National Research? Shares of NRC stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. What other stocks do shareholders of National Research own? Based on aggregate information from My MarketBeat watchlists, some other companies that National Research investors own include Meta Platforms (META), NVIDIA (NVDA), Tesla (TSLA), Alphabet (GOOG), Netflix (NFLX), Advanced Micro Devices (AMD) and JPMorgan Chase & Co. (JPM). Company Calendar Record date for 7/11 Dividend6/27/2025Ex-Dividend for 7/11 Dividend6/27/2025Dividend Payable7/11/2025Last Earnings7/28/2025Today7/30/2025Next Earnings (Estimated)8/05/2025Fiscal Year End12/31/2025Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeNASDAQ SectorBusiness Services Industry BUSINESS INFO SVC Sub-IndustryBusiness Services Current SymbolNASDAQ:NRC CIK70487 Webwww.nrchealth.com Phone(402) 475-2525Fax402-475-9061Employees490Year Founded1981Profitability EPS (Trailing Twelve Months)$1.03 Trailing P/E Ratio17.45 Forward P/E RatioN/A P/E GrowthN/ANet Income$24.78 million Net Margins12.78% Pretax Margin22.80% Return on Equity76.61% Return on Assets18.33% Debt Debt-to-Equity Ratio1.98 Current Ratio0.54 Quick Ratio0.54 Sales & Book Value Annual Sales$143.06 million Price / Sales2.11 Cash Flow$1.27 per share Price / Cash Flow10.44 Book Value$1.36 per share Price / Book9.75Miscellaneous Outstanding Shares22,780,000Free Float22,329,000Market Cap$302.06 million OptionableOptionable Beta0.45 Social Links A Guide To High-Short-Interest StocksMarketBeat's analysts have just released their top five short plays for August 2025. Learn which stocks have the most short interest and how to trade them. Enter your email address to see which companies made the list.Get This Free Report This page (NASDAQ:NRC) was last updated on 7/30/2025 by MarketBeat.com Staff From Our PartnersAI Frenzy Could Send ‘EarnPhone’ SoaringThe hidden fuel behind AI? Your phone. Billions of data points — from your clicks, swipes, scrolls, and sea...Mode Mobile | SponsoredNvidia’s next AI move could catch traders flat-footedTired of Missing Big AI Moves Like Nvidia? You’re not the problem—your trading system is. Tim’s XGPT system...Timothy Sykes | SponsoredEx-Hedge Fund Manager Uncovers $100 Trillion Land ShiftTrump's Radical New Plan Could Enrich Thousands This isn't a campaign stunt. It's a $100 trillion move to u...Stansberry Research | SponsoredI was wrong about TrumpI made a mistake. A mistake I feel very foolish about. After speaking with Donald Trump and some of his ...Porter & Company | SponsoredThe Fed Just Froze You Out (Again)The Fed’s holding rates steady—again. No clarity. No yield. No relief. But one income strategy is quietly t...Investors Alley | SponsoredMarket Crash Warning: How to Protect Your Wealth Before August 12thChina tariffs hit August 12—and experts warn a market meltdown may follow. A free guide from American Alter...American Alternative | SponsoredSomething BIG is about to hit the stock marketMost investors won’t see it coming—but Weiss Ratings says a major market event is brewing. Their system jus...Weiss Ratings | SponsoredThe $1 Trillion Event Tesla Still Hasn’t Recovered FromIn 2010, a “Flash Crash” erased $1 trillion in minutes. Now, one trading legend says it’s happening again—insi...Brownstone Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding National Research Corporation Please log in to your account or sign up in order to add this asset to your watchlist. Share National Research With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.